Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

  • Exchange: New York
  • Sector: Health Care
  • Industry: Health Care Facilities & Svcs
  • Sub-Industry: Health Care Services

Laboratory Corp of America Holdings

+ Add to Watchlist


121.4200 USD 1.0600 0.88%

As of 20:04:06 ET on 05/22/2015.

Snapshot for Laboratory Corp of America Holdings (LH)

Open: 120.4300 Day's Range: 119.8500 - 125.4500 Volume: 2,501,694
Previous Close: 120.3600 52wk Range: 95.6100 - 131.1900 1-Yr Rtn: +20.52%

Stock Chart for LH

No chart data available.
  • LH:US 121.4200
  • 1D
  • 1M
  • 1Y
Interactive LH Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for LH

Current P/E Ratio (ttm) 19.4640
Estimated P/E(12/2015) 15.9218
Relative P/E vs. SPX 1.0360
Earnings Per Share (USD) (ttm) 6.2382
Est. EPS (USD) (12/2015) 7.6260
Est. PEG Ratio 1.3942
Market Cap (M USD) 12,190.57
Shares Outstanding (M) 100.40
30 Day Average Volume 1,249,154
Price/Book (mrq) 2.7011
Price/Sale (ttm) 1.6503
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 07/17/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for LH

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for LH

Laboratory Corporation of America Holdings is a clinical laboratory company that offers clinical laboratory tests used by the medical profession in routine testing, patient diagnosis, and in the monitoring and treatment of disease. The Company develops specialty testing operations, such as oncology testing, HIV genotyping and phenotyping, diagnostic genetics and clinical trials.

David P KingChairman/PresidentJames T Boyle JrChief Executive Officer
Glenn A EisenbergExec VP/CFO/TreasurerMark Elliott BrecherSenior VP/Chief Medical Ofcr
More Company Profile & Key Executives for LH

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil